Log in

ASX:MDRMedadvisor Stock Price, Forecast & News

A$0.52
+0.02 (+3.96 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.50
Now: A$0.53
A$0.53
50-Day Range
A$0.53
MA: A$0.52
A$0.53
52-Week Range
A$0.28
Now: A$0.53
A$0.68
Volume719,064 shs
Average VolumeN/A
Market Capitalization$129.12 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedAdvisor Limited develops and delivers software for personal medication management in Australia. It develops and deploys the MedAdvisor, a medication and adherence platform that connects health professionals with patients using mobile and Web technologies; and PlusOne, a software platform, which allow pharmacies to connect with patients via SMS, App, Web/email or Landline. MedAdvisor Limited is based in Camberwell, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.80 million
Cash FlowA$0.07 per share
Book ValueA$0.08 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$129.12 million
Next Earnings DateN/A
OptionableOptionable

Receive MDR News and Ratings via Email

Sign-up to receive the latest news and ratings for MDR and its competitors with MarketBeat's FREE daily newsletter.

Medadvisor (ASX:MDR) Frequently Asked Questions

How has Medadvisor's stock been impacted by COVID-19 (Coronavirus)?

Medadvisor's stock was trading at A$0.42 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MDR stock has increased by 25.0% and is now trading at A$0.53. View which stocks have been most impacted by Coronavirus.

Has Medadvisor been receiving favorable news coverage?

Media coverage about MDR stock has been trending negative on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medadvisor earned a news sentiment score of -2.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the company's share price in the next few days. View the latest news about Medadvisor.

Who are some of Medadvisor's key competitors?

Who are Medadvisor's key executives?

Medadvisor's management team includes the following people:
  • Mr. Robert Read BComm(Mgt), BA(Psych), GAICD, MD, CEO & Exec. Director
  • Mr. Joshua Swinnerton MEI, GradCert Eng., BE, BCS(Hons)., Founder, Chief Product Officer & Exec. Director
  • Mr. Carlo Campiciano, Company Sec. & CFO
  • Mr. Victor Kovalev, CTO & Head of Product
  • Jennifer Duraisingam, Corp. Communications Mang.

What is Medadvisor's stock symbol?

Medadvisor trades on the ASX under the ticker symbol "MDR."

What is Medadvisor's stock price today?

One share of MDR stock can currently be purchased for approximately A$0.53.

How big of a company is Medadvisor?

Medadvisor has a market capitalization of $129.12 million and generates $8.80 million in revenue each year.

What is Medadvisor's official website?

The official website for Medadvisor is www.medadvisor.com.au.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.